Disclosed positions

Estimated from their latest filings — positions may have changed since

$38.65M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ELVNEnliven Therapeutics, Inc.	758,938	$50.92	$38.65M	100%	2026-02-12

ELVN

Enliven Therapeutics, Inc.

$38.65M

758,938 sh

All filings on record

Every Form 4 transaction we track for this filer

all 22buys 0sells 21

Stock	Transaction	Date	~6mo later
ELVNEnliven Therapeutics, Inc.	Grant — · 18,750 sh	2026-02-12	—
ELVNEnliven Therapeutics, Inc.	Sell $145.2K · 5,000 sh	2026-02-06	—
ELVNEnliven Therapeutics, Inc.	Sell $390.3K · 14,509 sh	2026-01-20	—
ELVNEnliven Therapeutics, Inc.	Sell $144.8K · 5,491 sh	2026-01-20	—
ELVNEnliven Therapeutics, Inc.	Sell $1.46M · 50,000 sh	2026-01-09	—
ELVNEnliven Therapeutics, Inc.	Sell $1.03M · 41,198 sh	2026-01-09	—
ELVNEnliven Therapeutics, Inc.	Sell $842.5K · 33,802 sh	2026-01-08	—
ELVNEnliven Therapeutics, Inc.	Sell $151.0K · 7,500 sh	2026-01-08	—
ELVNEnliven Therapeutics, Inc.	Sell $84.2K · 5,000 sh	2025-12-19	—
ELVNEnliven Therapeutics, Inc.	Sell $11.4K · 492 sh	2025-11-19	—
ELVNEnliven Therapeutics, Inc.	Sell $267.8K · 12,008 sh	2025-11-19	—
ELVNEnliven Therapeutics, Inc.	Sell $276.0K · 12,500 sh	2025-10-20	—
ELVNEnliven Therapeutics, Inc.	Sell $81.0K · 4,000 sh	2025-09-26	—
ELVNEnliven Therapeutics, Inc.	Sell $30.0K · 1,500 sh	2025-09-23	—
ELVNEnliven Therapeutics, Inc.	Sell $42.6K · 2,130 sh	2025-09-19	—
ELVNEnliven Therapeutics, Inc.	Sell $93.1K · 4,870 sh	2025-09-19	—
ELVNEnliven Therapeutics, Inc.	Sell $150.1K · 7,500 sh	2025-08-21	—
ELVNEnliven Therapeutics, Inc.	Sell $98.1K · 5,000 sh	2025-08-19	—
ELVNEnliven Therapeutics, Inc.	Sell $13.2K · 576 sh	2025-07-21	—
ELVNEnliven Therapeutics, Inc.	Sell $265.5K · 11,924 sh	2025-07-21	—
ELVNEnliven Therapeutics, Inc.	Sell $267.5K · 12,500 sh	2025-06-20	—
ELVNEnliven Therapeutics, Inc.	Sell $150.2K · 7,500 sh	2025-06-03	—

ELVNGrant

2026-02-12 · Enliven Therapeutics, Inc.

18,750

—

ELVNSell

2026-02-06 · Enliven Therapeutics, Inc.

$145.2K

—

ELVNSell

2026-01-20 · Enliven Therapeutics, Inc.

$390.3K

—

ELVNSell

2026-01-20 · Enliven Therapeutics, Inc.

$144.8K

—

ELVNSell

2026-01-09 · Enliven Therapeutics, Inc.

$1.46M

—

ELVNSell

2026-01-09 · Enliven Therapeutics, Inc.

$1.03M

—

ELVNSell

2026-01-08 · Enliven Therapeutics, Inc.

$842.5K

—

ELVNSell

2026-01-08 · Enliven Therapeutics, Inc.

$151.0K

—

ELVNSell

2025-12-19 · Enliven Therapeutics, Inc.

$84.2K

—

ELVNSell

2025-11-19 · Enliven Therapeutics, Inc.

$11.4K

—

ELVNSell

2025-11-19 · Enliven Therapeutics, Inc.

$267.8K

—

ELVNSell

2025-10-20 · Enliven Therapeutics, Inc.

$276.0K

—

ELVNSell

2025-09-26 · Enliven Therapeutics, Inc.

$81.0K

—

ELVNSell

2025-09-23 · Enliven Therapeutics, Inc.

$30.0K

—

ELVNSell

2025-09-19 · Enliven Therapeutics, Inc.

$42.6K

—

ELVNSell

2025-09-19 · Enliven Therapeutics, Inc.

$93.1K

—

ELVNSell

2025-08-21 · Enliven Therapeutics, Inc.

$150.1K

—

ELVNSell

2025-08-19 · Enliven Therapeutics, Inc.

$98.1K

—

ELVNSell

2025-07-21 · Enliven Therapeutics, Inc.

$13.2K

—

ELVNSell

2025-07-21 · Enliven Therapeutics, Inc.

$265.5K

—

ELVNSell

2025-06-20 · Enliven Therapeutics, Inc.

$267.5K

—

ELVNSell

2025-06-03 · Enliven Therapeutics, Inc.

$150.2K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.